Data / Form D filings / T2 Biosystems, Inc.
T2 Biosystems, Inc.: Form D filings
T2 Biosystems, Inc., a health care company in Lexington, MA, filed 4 Form D notices with the SEC between 2010 and 2016. The latest, on September 27, 2016, reports $39.7 million sold of a $39.7 million offering to 1 investor.
Find out what T2 Biosystems, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 HARTWELL AVENUE, Lexington, MA, 02421
- Phone
- (781) 457-1200
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1492674
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 27, 2016 | New notice | $39,723,037 | $39,723,037 | $0 | 1 | Sep 21, 2016 | sec.gov |
| Mar 28, 2013 | New notice | $399,999,997 | $399,999,997 | $0 | 16 | Mar 22, 2013 | sec.gov |
| Aug 10, 2011 | New notice | $22,999,999 | $22,999,999 | $0 | 14 | Aug 3, 2011 | sec.gov |
| May 28, 2010 | New notice | $19,999,997 | $14,845,001 | $5,154,996 | 13 | May 13, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David W. Elsbree | Director | |
| Rahul M. Dhanda | Executive Officer | |
| John McDonough | Executive Officer, Director | |
| Tom Lowery, Ph.D. | Executive Officer | |
| Michael M. Gibbs, Esq. | Executive Officer | |
| Joanne Spadoro, Ph.D. | Executive Officer | |
| Michael A. Cima, Ph.D. | Director | |
| John W. Cumming | Director | |
| Seymour M. Liebman | Director | |
| Michael A. Pfaller, M.D. | Executive Officer | |
| Adrian M. Jones | Director | |
| David P. Harding | Executive Officer | |
| Shawn Lynch | Executive Officer | |
| Steven M. Scampini | Executive Officer | |
| Stanley M. Lapidus | Director | |
| Josh A. Bilenker, M.D. | Director |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
- REVBIO, INC. $15 million · Oct 2, 2026
- Fresenius Medical Care Will Clayton, LLC $3.8 million · Sep 21, 2026
- DynamiCare Health, Inc. $720,000 · Sep 10, 2026
- OnPoint Surgical, Inc. $18 million · Sep 1, 2026
Every Form D from the week of Sep 26, 2016 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what T2 Biosystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.